Germany tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.0% during the forecast period. Germany is significant market has been one of the significant market in the European tuberculosis diagnostic and treatment market. In 2018, a total of 5,429 tuberculosis (TB) cases were notified in Germany. The number of total cases remained almost unchanged in comparison to the 2015 which was 5,828 cases and incidence of 7.1. According to the Robert Koch institute, the tuberculosis incidence in foreign nationals residing in Germany was 19 times higher than the incidence in German citizens. This difference between the two groups increased in comparison to the previous year (16.6 times higher). The largest difference was observed in young adults. Overall, Germans comprised of 30.9 % of all tuberculosis cases, whereas the remaining 69.1 % of all cases were foreign nationals. Foreign nationals affected by tuberculosis were younger than German nationals.
Visit for Global Tuberculosis Diagnosis and Treatment
Market Report at: https://www.omrglobal.com/industry-reports/tuberculosis-diagnosis-and-treatment-market-size
The German TB-surveillance system is essential for timely identification of epidemiological trends and their interpretation in the context of factors that potentially influence the epidemiological situation. Rising case numbers in the non-German population, multidrug-resistant and extensively drug-resistant TB, and a high proportion of infectious pulmonary TB indicate that TB remains a significant public health issue in Germany, with an increasing burden among high risk groups.
Germany tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline PLC, Hain Lifescience GmbH, Johnson & Johnson, OTSUKA NOVEL PRODUCTS GMBH, Pifzer, Inc., Qiagen GMBH and Sandoz Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Research Methodology
The market study of the Germany Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. Germany Tuberculosis Diagnosis and Treatment Market by Drugs Type
5.1.1. First Line Drugs
5.1.2. Second Line Drugs
5.2. Germany Tuberculosis Diagnosis and Treatment Market by Diagnosis
5.2.1. Laboratory Testing
5.2.2. Nucleic Acid Amplification Test
5.2.3. Mantoux Test
5.2.4. Radiography
5.2.5. Drug Susceptibility Testing
6 Company Profiles
6.1 Abbott Laboratories
6.2 Becton, Dickinson and Co.
6.3 F. HOFFMANN-LA ROCHE LTD.
6.4 GlaxoSmithKline PLC
6.5 Hain Lifescience GmbH
6.6 Johnson & Johnson
6.7 OTSUKA NOVEL PRODUCTS GMBH
6.8 Pifzer, Inc.
6.9 Qiagen GMBH
6.10 Sandoz Inc.
1. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
2. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DRUGS TYPE, 2018-2025 ($ MILLION)
3. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
1. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET SHARE BY COUNTRY, 2018 VS 2025 (%)
2. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET SHARE BY DRUGS TYPE, 2018 VS 2025 (%)
3. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2018 VS 2025 (%)
4. GERMANY TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)